Latest Tri Locum Partners LP Stock Portfolio
About Tri Locum Partners LP and 13F Hedge Fund Stock Holdings
On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, Tri Locum Partners LP reported an equity portfolio of $770.1 Millions as of 31 Dec, 2025.
The top stock holdings of Tri Locum Partners LP are JNJ, DHR, LLY. The fund has invested 16.2% of it's portfolio in JOHNSON & JOHNSON and 10.3% of portfolio in DANAHER CORPORATION .
The fund managers got completely rid off MERCK & CO INC (MRK), SOLENO THERAPEUTICS INC (SLNO) and ABBVIE INC (ABBV) stocks. They significantly reduced their stock positions in VERA THERAPEUTICS INC (VERA), AXSOME THERAPEUTICS INC (AXSM) and ARGENX SE (ARGX). Tri Locum Partners LP opened new stock positions in DANAHER CORPORATION (DHR), ELI LILLY & CO (LLY) and BOSTON SCIENTIFIC CORP (BSX). The fund showed a lot of confidence in some stocks as they added substantially to DIANTHUS THERAPEUTICS INC, JOHNSON & JOHNSON (JNJ) and ASCENDIS PHARMA A/S (ASND).
The top stock holdings of Tri Locum Partners LP are JNJ, DHR, LLY. The fund has invested 16.2% of it's portfolio in JOHNSON & JOHNSON and 10.3% of portfolio in DANAHER CORPORATION .
The fund managers got completely rid off MERCK & CO INC (MRK), SOLENO THERAPEUTICS INC (SLNO) and ABBVIE INC (ABBV) stocks. They significantly reduced their stock positions in VERA THERAPEUTICS INC (VERA), AXSOME THERAPEUTICS INC (AXSM) and ARGENX SE (ARGX). Tri Locum Partners LP opened new stock positions in DANAHER CORPORATION (DHR), ELI LILLY & CO (LLY) and BOSTON SCIENTIFIC CORP (BSX). The fund showed a lot of confidence in some stocks as they added substantially to DIANTHUS THERAPEUTICS INC, JOHNSON & JOHNSON (JNJ) and ASCENDIS PHARMA A/S (ASND).
Tri Locum Partners LP Annual Return Estimates Vs S&P 500
- Performance
New Buys
| Ticker | $ Bought |
|---|---|
| danaher corporation | 79,406,600 |
| eli lilly & co | 68,010,000 |
| boston scientific corp | 49,630,400 |
| teva pharmaceutical inds ltd | 44,813,300 |
| ionis pharmaceuticals inc | 44,078,000 |
| nuvalent inc | 30,918,400 |
| dexcom inc | 27,981,600 |
New stocks bought by Tri Locum Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| dianthus therapeutics inc | 240 |
| johnson & johnson | 99.17 |
| ascendis pharma a/s | 51.59 |
| madrigal pharmaceuticals inc | 27.05 |
Additions to existing portfolio by Tri Locum Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| vera therapeutics inc | -32.31 |
| axsome therapeutics inc | -30.98 |
| argenx se | -13.26 |
| united therapeutics corp del | -1.04 |
Tri Locum Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| avadel pharmaceuticals plc | -11,068,600 |
| soleno therapeutics inc | -30,459,500 |
| merck & co inc | -37,506,100 |
| xenon pharmaceuticals inc | -14,699,000 |
| korro bio inc | -16,175,500 |
| stevanato group s p a | -8,572,480 |
| biohaven ltd | -2,239,180 |
| tarsus pharmaceuticals inc | -7,087,620 |
Tri Locum Partners LP got rid off the above stocks
Sector Distribution
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 85.2 |
| Others | 14.8 |
Market Cap. Distribution
- LARGE-CAP
- MEGA-CAP
- UNALLOCATED
- MID-CAP
| Category | % |
|---|---|
| LARGE-CAP | 46.1 |
| MEGA-CAP | 25 |
| UNALLOCATED | 14.8 |
| MID-CAP | 14.1 |
Stocks belong to which Index?
- S&P 500
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| S&P 500 | 45.4 |
| Others | 34 |
| RUSSELL 2000 | 20.6 |
Tri Locum Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Tri Locum Partners LP
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARGX | argenx se | 4.11 | 37,653 | 31,664,300 | reduced | -13.26 | ||
| ASND | ascendis pharma a/s | 7.34 | 265,015 | 56,511,800 | added | 51.59 | ||
| AXSM | axsome therapeutics inc | 4.78 | 201,627 | 36,825,200 | reduced | -30.98 | ||
| BSX | boston scientific corp | 6.44 | 520,508 | 49,630,400 | new | |||
| DHR | danaher corporation | 10.31 | 346,875 | 79,406,600 | new | |||
| DXCM | dexcom inc | 3.63 | 421,600 | 27,981,600 | new | |||
| IONS | ionis pharmaceuticals inc | 5.72 | 557,174 | 44,078,000 | new | |||
| JNJ | johnson & johnson | 16.21 | 603,143 | 124,820,000 | added | 99.17 | ||
| LLY | eli lilly & co | 8.83 | 63,284 | 68,010,000 | new | |||
| MDGL | madrigal pharmaceuticals inc | 6.50 | 86,023 | 50,094,600 | added | 27.05 | ||
| MRK | merck & co inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| NUVL | nuvalent inc | 4.02 | 307,371 | 30,918,400 | new | |||
| PRAX | praxis precision medicines i | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SLNO | soleno therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| STVN | stevanato group s p a | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| TARS | tarsus pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| TEVA | teva pharmaceutical inds ltd | 5.82 | 1,435,860 | 44,813,300 | new | |||
| UTHR | united therapeutics corp del | 7.65 | 120,921 | 58,918,800 | reduced | -1.04 | ||
| VERA | vera therapeutics inc | 5.30 | 805,689 | 40,800,100 | reduced | -32.31 | ||